Why targeted therapeutics have provided benefit in psoriasis: looking at IL-17 biology
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2130758
Abstract: ABSTRACT Introduction Psoriasis is an inflammatory, chronic and immune-mediated disease that can affect the skin and joints. Pro-inflammatory cytokines have a dominant role in the pathogenesis of this heterogeneous disease in which the IL-23/IL-17 axis… read more here.
Keywords: therapeutics provided; targeted therapeutics; benefit psoriasis; provided benefit ... See more keywords